Theoni (Tania) Katopodi
About Theoni (Tania) Katopodi
Theoni (Tania) Katopodi is a Product Development Scientist at Instil Bio, where she leads the development of tumor-infiltrating lymphocyte growth protocols. She has extensive experience in research and academia, having held various positions at institutions such as the University of Manchester, University of Athens, and Omnigen S.A.
Current Role at Instil Bio
Theoni Katopodi currently serves as a Product Development Scientist at Instil Bio, a position she has held since 2018. In this role, she leads the development of tumor-infiltrating lymphocyte (TIL) growth protocols for various cancer indications. Additionally, she manages a Knowledge Transfer Partnership (KTP) research associate, contributing to the advancement of research and development within the organization. Katopodi also plays a key role in establishing collaborations between Instil Bio UK and the University of Manchester, enhancing the synergy between industry and academia.
Previous Experience in Research and Development
Prior to her current role, Katopodi accumulated extensive experience in research and development across various institutions. She worked as a Research Associate at the University of Liverpool from 2015 to 2016 and held a Postdoctoral Research Assistant position at The University of Manchester from 2016 to 2018. Her earlier roles include serving as a Postdoctoral Scientist at the University of Athens from 2014 to 2015 and as a Senior Cell Biologist at Omnigen S.A. from 2011 to 2013. Her career began with positions as a Research Technician and Research Scientist in Athens and Manchester.
Educational Background in Life Sciences
Theoni Katopodi has a solid educational foundation in life sciences. She earned her Bachelor of Science (BS) in Molecular Genetics from the University of Sussex from 1994 to 1997. She then pursued a Master of Science (MSc) in Medical Genetics at Brunel University, completing her studies in 1998. Katopodi further advanced her education by obtaining a Doctor of Philosophy (PhD) in Biochemistry/Cell Biology from The University of Manchester, where she studied from 2003 to 2007.
Research Contributions and Leadership
Throughout her career, Katopodi has made significant contributions to research in the field of cell biology and cancer treatment. She has led the development of protocols for tumor-infiltrating lymphocytes, which are crucial for advancing cancer therapies. Her leadership extends to managing research associates and fostering collaborations between academic institutions and industry, particularly between Instil Bio and the University of Manchester. These efforts aim to bridge the gap between research findings and practical applications in cancer treatment.